Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer
| Class:Id | LiteratureReference:9647026 |
|---|
| _displayName | An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer |
|---|
| _timestamp | 2019-05-29 18:43:15 |
|---|
| author | [Person:9646949] Hanker, Ariella B
[Person:9647006] Brewer, Monica Red
[Person:9646939] Sheehan, Jonathan H
[Person:9646959] Koch, James P
[Person:9646937] Sliwoski, Gregory R
[Person:9646996] Nagy, Rebecca
[Person:9647012] Lanman, Richard
[Person:6801837] Berger, Michael F
[Person:9646802] Hyman, David M
[Person:6790436] Solit, David B
[Person:5662780] He, Jie
[Person:1181052] Miller, V
[Person:5672167] Cutler, Richard E
[Person:9646431] Lalani, Alshad S
[Person:9646972] Cross, Darren
[Person:5683787] Lovly, Christine M
[Person:9647020] Meiler, Jens
[Person:2399806] Arteaga, Carlos L |
|---|
| created | [InstanceEdit:9647017] Orlic-Milacic, Marija, 2019-05-29 |
|---|
| journal | Cancer Discov |
|---|
| pages | 575-585 |
|---|
| pubMedIdentifier | 28274957 |
|---|
| title | An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer |
|---|
| volume | 7 |
|---|
| year | 2017 |
|---|
| (literatureReference) | [EntityWithAccessionedSequence:9646823] ERBB2 T798I [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:9646825] ERBB2 T798M [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:9646827] ERBB2 L869R [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:9647202] p-6Y-ERBB2 T798I [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:9647213] p-6Y-ERBB2 L869R [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:9647218] p-6Y-ERBB2 T798M [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:9654615] p-Y-ERBB2 T798M [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:9654618] p-Y-ERBB2 T798I [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:9654730] p-Y-ERBB2 L869R [plasma membrane] [Homo sapiens]
[Pathway:1227990] Signaling by ERBB2 in Cancer [Homo sapiens] |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer (9647026)
